438 related articles for article (PubMed ID: 25576295)
1. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
Wan S; Wu Y; Zhou X; Chen Y; An J; Yu X; Zhang H; Yang H; Xing J
PLoS One; 2015; 10(4):e0124471. PubMed ID: 25894340
[TBL] [Abstract][Full Text] [Related]
5. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
7. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
[TBL] [Abstract][Full Text] [Related]
8. Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.
Dai J; Hu Z; Dong J; Xu L; Pan S; Jiang Y; Jin G; Chen Y; Shen H
Int J Cancer; 2012 Feb; 130(3):671-6. PubMed ID: 21412764
[TBL] [Abstract][Full Text] [Related]
9. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
[TBL] [Abstract][Full Text] [Related]
12. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
[TBL] [Abstract][Full Text] [Related]
13. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.
Guo X; Li H; Fei F; Liu B; Li X; Yang H; Chen Z; Xing J
Mol Carcinog; 2015 Jun; 54 Suppl 1():E52-60. PubMed ID: 24782339
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
16. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
[TBL] [Abstract][Full Text] [Related]
17. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.
Guo X; Chen C; Liu B; Wu Y; Chen Y; Zhou X; Huang X; Li X; Yang H; Chen Z; Xing J
Tumour Biol; 2015 May; 36(5):3931-9. PubMed ID: 25578492
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.
Xu Y; Wang Y; Liu H; Kang X; Li W; Wei Q
Oncotarget; 2016 Sep; 7(38):61716-61727. PubMed ID: 27557513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]